Alder Bio Picks AbbVie’s Nadia Dac for Chief Commercial Officer

Nadia Dac has joined Alder BioPharmaceuticals (NASDAQ: [[ticker:ALDR]]) as chief commercial officer. She comes to the Bothell, WA, biotech from AbbVie (NYSE: [[ticker:ABBV]]), where she was vice president of global specialty commercial development. Her experience also includes positions at Novartis (NYSE: [[ticker:NVS]]), Biogen (NASDAQ: [[ticker:BIIB]]), and Pfizer (NYSE: [[ticker:PFE]]). In February, Alder filed for FDA approval of eptinezumab, an antibody drug developed to prevent migraine headaches.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan